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Introduction: Postoperative endoscopic recurrence (PER) is the initial event after intestinal
resection  in Crohn’s disease (CD), and after a few years most patients present with progres-
sive  symptoms and complications related to the disease. The identiﬁcation of risk factors for
PER can help in the optimization of postoperative therapy and contribute to its prevention.
Methods:  Retrospective, longitudinal, multicenter, observational study involving patients
with  CD who underwent ileocolic resections. The patients were allocated into two groups
according  to the presence of PER and the variables of interest were  analyzed to identify the
associated  factors for recurrence.
Results:  Eighty-ﬁve patients were included in the study. The mean period of the ﬁrst postop-
erative  colonoscopy was 12.8 (3–120) months and PER was observed in 28 patients (32.9%).
There  was no statistical difference in relation to gender, mean age, duration of CD, family
history,  previous intestinal resections, smoking, Montreal classiﬁcation, blood transfusion,
residual  CD, surgical technique, postoperative complications, presence of granulomas at
histology, specimen extension and use of postoperative biological therapy. The preoperative
use  of corticosteroids was the only variable that showed a signiﬁcant difference between
the  groups in univariate analysis, being more common in patients with PER (42.8% vs. 21%;
p = 0.044).
Conclusions: PER was observed in 32.9% of the patients. The preoperative use of corticoste-
roids  was the only risk factor associated with PER in this observational analysis.©  2014 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. 
 Study conducted at The Colorectal Surgery Unit, Hospital Universitário Cajuru (SeCoHUC), PUC-PR, Curitiba, PR, Brazil.
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Fatores  de  risco  para  recorrência  endoscópica  pós-operatória  na  doenc¸a
de  Crohn:  um  estudo  observacional  brasileiro
Palavras-chave:
Doenc¸a  de Crohn
Recorrência
Fatores  de risco
r  e  s  u  m  o
Introduc¸ão: Recorrência endoscópica pós-operatória (REP) é evento inicial após ressecc¸ões
intestinais na doenc¸a  de Crohn (DC) e grande parte dos pacientes progride com sintomas
e complicac¸ões  relacionados à doenc¸a  em alguns anos. A identiﬁcac¸ão  dos fatores de
risco para REP pode auxiliar na otimizac¸ão  da terapia pós-operatória e contribuir para sua
prevenc¸ão.
Método: Estudo retrospectivo, longitudinal, multicêntrico e observacional, realizado com
pacientes portadores de DC, submetidos à ressecc¸ão  ileocólica. Os pacientes foram alocados
em dois grupos de acordo com a presenc¸a  de REP e as variáveis de interesse foram analisadas
a ﬁm de se identiﬁcar os fatores associados à recorrência.
Resultados: Oitenta e cinco pacientes foram incluídos no estudo. O tempo médio da primeira
colonoscopia pós-operatória foi de 12,8 (3-120) meses e REP foi observada em 28 pacientes
(32,9%). Não houve diferenc¸a  estatística entre os grupos em relac¸ão  a gênero, média de
idade, durac¸ão  da DC, história familiar, ressecc¸ão  intestinal prévia, tabagismo, classiﬁcac¸ão
de  Montreal, transfusão sanguínea, DC residual, técnica cirúrgica, complicac¸ões  pós-
operatórias, presenc¸a  de granuloma, extensão do espécime e utilizac¸ão  de biológicos após
a cirurgia. O uso pré-operatório de corticosteroides foi a única variável que apresentou
signiﬁcativa diferenc¸a  na análise univariada, sendo mais frequente nos pacientes que apre-
sentaram REP (42.8% vs. 21%, p = 0.044).
Conclusões:  REP foi observada em 32.9% dos pacientes. A utilizac¸ão  pré-operatória de corti-
costeroides foi o único fator associado à REP nesta análise observacional.
© 2014 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Despite the progress in the medical therapy of Crohn’s disease
(CD),  with better results after the use of immunosuppressive
drugs and antagonists of tumor necrosis factor alpha (anti-
TNFs),  about 70% of patients will require surgery throughout
their  lives, often due to complications associated with the
disease,  such as ﬁstulae, abscesses and ﬁbrotic strictures.1–3
Once undergoing intestinal resection, these patients are at
increased  risk of future reoperations and 30–70% will require
a  new procedure in a 10-year interval.1
Postoperative recurrence can be deﬁned by different ﬁnd-
ings,  including clinical, endoscopic, histological, radiological
and  surgical Characteristics.4 The time to recurrence follows a
deﬁnite pattern, with endoscopic recurrence being a precursor
of  symptomatic (clinical) recurrence.5 Upon endoscopic recur-
rence,  about 20% of patients have concomitant clinical relapse
within  1 year and above 50% at 5 years.2,5,6
Besides preceding the symptoms, the severity of endo-
scopic  lesions predicts the likelihood of subsequent devel-
opment  of clinical recurrence and the need for another
operation.7 Accordingly, the use of the classiﬁcation of endo-
scopic  recurrence described by Rutgeerts et al.8 plays an
important role in the standardization of postoperative endo-
scopic  ﬁndings.
Some  publications have suggested the stratiﬁcation of
postoperative endoscopic recurrence (PER) risk, based on
patient-related characteristics, on surgical ﬁndings and on the
CD  itself, in order to determine the best type of postoperativeprophylaxis.6,7 The factors commonly used for this stratiﬁca-
tion  are those with the highest level of evidence: prior bowel
resection,  penetrating disease and smoking.7,9,10
In Brazil, there is scarce published data on factors asso-
ciated  with postoperative endoscopic recurrence. There is a
need to determine which risk factors for PER recognized in the
international  literature can be applied to patients and at refer-
ral  centers in our country, in order to properly stratify the risks
of  recurrence, with subsequent improvement in postoperative
management.
Thus,  the aim of this study was  to examine rates of PER
and  determine which risk factors would be associated with
its  occurrence in a cohort of Brazilian patients undergoing
ileocolic resections for CD.
Method
This study was approved by the Ethics Committee on
Research, Center for Bioethics, Pontifícia Universidade
Católica do Paraná (PUCPR), based on Opinion of Pre-
sentation Certiﬁcate for Ethics Assessment (CAAE) nr.
19923413.1.0000.0020 (second version), performed by the
Plataforma  Brasil website.
This  was a retrospective, longitudinal, multicenter, obser-
vational  study involving patients with CD undergoing ileocolic
resections  in the period from January 2002 to December 2012,
from  four referral centers in the management of inﬂam-
matory bowel diseases (IBD) in southern and southeastern
Brazil.
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Table 1 – Detailed description of the Rutgeerts’ score
(adapted from Rutgeerts et al.)8.
Rutgeerts score Endoscopic description of ﬁndings
i0 No lesions
i1  ≤5 aphthous ulcerations
i2 >5 aphthous ulcerations with normal mucosa
between them, or normal areas between larger
ulcerations, or ulcerations limited to the ileocolic
anastomosis
i3 Diffuse aphthous ileitis with diffusely inﬂamed
mucosa
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icantly higher number of patients in the group with
PER compared to the group without PER (42.8% vs. 21%
P  = 0.044).i4 Diffuse inﬂammation with large ulcerations,
nodules or stenoses
Patients with CD, aged between 14 and 80 years, who
nderwent ileocolic resection with primary anastomosis and
ith  postoperative ileocolonoscopy during the evaluation
eriod were  included in the study. Patients with unde-
ermined inﬂammatory bowel disease, aged under 14 and
ver  80 years; patients undergoing other types of surgi-
al  procedures (enterectomies, enteroplasties, colectomies,
leostomies or other procedures without anastomosis) or who
id  not undergo postoperative ileocolonoscopy; and patients
ith  no follow-up after surgery in their respective institution
ere  excluded.
ollection  and  processing  of  data
atients were  previously identiﬁed in databases of IBD opera-
ions  conducted at the four referral units. After conﬁrmation
f  the inclusion criteria, data were  collected by reviewing elec-
ronic  medical records and ﬁlling a pre-established protocol.
n  the absence of data recorded in medical records, phone calls
o  patients, when necessary to supplement the information,
ere  performed.
eﬁnition  of  recurrence  and  study  groups
he occurrence of PER was  assessed by the ﬁrst postoperative
olonoscopic examination after ileocolic resection. The deﬁ-
ition  of PER was  based on the Rutgeerts’ score,8 deﬁned as i2,
3  or i4 at ileocolonoscopy. The Rutgeerts’ score is illustrated
n  Table 1.
Patients  were  allocated into two groups according to the
resence  or absence of endoscopic recurrence: group without
ecurrence (Rutgeerts i0/i1) and group with recurrence (Rut-
eerts  ≥ i2). From these groups, the variables of interest were
ested  in order to identify possible factors associated with PER,
hich would be designated as risk factors if statistical signif-
cance  was  reached.
tatistical  analysis
or statistical analysis the SPSS v.20 software was  used. For
ualitative  variables, we used Fisher exact test or chi-squared
est.  For quantitative variables, the Student’s t test or non-
arametric Mann–Whitney test was  used. Univariate analysis
as  performed to determine the association between each
ndependent variable and the presence or absence of PER. Sta-
istical  signiﬁcance was  deﬁned as P < 0.05.;3 4(3):141–147  143
Results
During the study period, 94 patients with CD underwent
ileocolic resection in the four referral units. Of these, nine
were  excluded because they had not undergone colonoscopy
postoperatively. Thus, the series consisted of 85 patients
(Fig.  1).
Hospital
Universitário
Cajuru
(n = 37)  
Clínica
Gastrosaúde
(n = 09) 
Ileocolic resections
n = 94
Ileocolonoscopy
n = 85
Rutgeerts i0/i1
n = 28 
Rutgeerts ≥ i2
n = 57  
UNESP
Botucatu
(n = 22) 
Hospital
Heliópolis
(n = 26)   
No colonoscopy
in follow-up
n=9
Fig. 1 – Study design and group division for evaluation
according to the presence or absence of PER, deﬁned as
Rutgeerts’  score ≥ i2.
The average time for the ﬁrst postoperative ileo-
colonoscopy was 12.8 (3–120) months. Considering recurrence
as  the presence of a Rutgeerts’ score ≥ i2, the PER rate was
32.9%  (n = 28). Table 2 illustrates in details the ﬁndings in rela-
tion  to the Rutgeerts’ score individually, showing the division
of  the study groups.
Table 2 – Identiﬁcation of the groups according to the
Rutgeerts’ score at the ﬁrst post-operative colonoscopy in
85  patients. Recurrence deﬁned as a Rutgeerts score ≥ i2.
Group Rutgeerts’ n (%) n (%)
W/o PER i0 25 (29.4) 57  (67.1)
i1  32 (37.6)
With  PER i2  10 (11.8) 28  (32.9)
i3  15 (17.6)
i4 3 (3.5)
Total  – 85 (100) 85 (100)
Patient-related factors were  compared between groups
(Table  3) and only the preoperative use of corticosteroids
was statistically signiﬁcant, being observed in a signif-Tables 4 and 5 illustrate the analysis among the variables
related to CD and to surgical procedures per se, respectively,
and  to study groups. As noted, none of these factors were
associated with PER in this study.
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Table 3 – Univariate analysis among factors related to patient and study groups regarding the presence of PER. Only
preoperative use of corticosteroids was statistically signiﬁcant.
Variable w/o PER (n = 57) With PER (n = 28) P value
Gender 0.487
Male 34 (59.7) 14 (50.0)
Female 23 (40.3) 14 (50.0)
Average age (years) 32.8 (14–63) 33.7 (15–57) 0.753
Family history of IBD 1 (1.7) 2 (7.1) 0.251
Previous resections for CD 17 (29.8) 8 (28.5) 1.000
Smoking status 10 (17.5) 7 (25.0) 0.565
Preoperative medications
Corticosteroids 12  (21.0) 12  (42.8) 0.044
AZA/6MP 30 (52.6) 17 (60.7) 0.498
Biologicals 15 (26.3) 4 (14.2) 0.129
Blood transfusion 8  (14.0) 4  (14.2) 1.000
Biologicals in the postoperative period 39 (68.4) 17  (60.7) 0.627
Type of postoperative biological 1.000
Adalimumab 20 (35.0) 8 (28.5)
Inﬂiximab 19 (33.3) 9 (32.1)
Table 4 – Univariate analysis among factors related to CD and study groups regarding the presence of PER.
Variable w/o PER (n = 57) With PER (n = 28) P value
CD Duration (months) 92.8 (2–300) 67.6 (10–192) 0.193
Montreal classiﬁcation
Age  at diagnosis 0.594
A1  7 (12.2) 3 (10.7)
A2 41 (71.9) 18 (64.2)
A3 9 (15.7) 7 (25.0)
Location 0.792
L1 22 (38.5) 12 (42.8)
L2 4 (7.0) 1 (3.5)
L3 31 (54.3) 15 (53.5)
L4 0 0
Phenotype of the disease 0.329
B1 4 (7.0) 1 (3.5)
B2 30 (52.6) 11 (39.2)
B3 23 (40.3) 16 (57.1)
Perianal (p) 11 (19.2) 5 (17.8) 1.000
Residual CD 8 (14.0) 6 (21.4) 0.535
Extension of the specimen (cm) 36.8 (10–150) 
Granuloma 23 (40.3) 
Discussion
The occurrence of PER is not an uncommon event in CD,
because  of the recurring nature of this disease. It is known that
endoscopic  recurrence precedes the clinical recurrence, which
in  turn precedes surgical recurrence. About 20% of patients
with  PER will have symptoms within a year, and over 50% in
ﬁve  years, making these people vulnerable to further compli-
cations  and possibly reoperations.6 Based on these data, the
main  issue in the current management of postoperative recur-
rence  of CD is to identify strong predictors of recurrence, in
order  to establish if patients would beneﬁt from postoperative
prophylaxis.11
The scarcity of national data is an obstacle to better deﬁne
the  behavior of postoperative CD in our country. To date, this31.4 (12–67) 0.536
11 (39.2) 1.000
is  the ﬁrst study including a large number of Brazilian patients
with  CD, which sought to identify risk factors for endoscopic
recurrence.
The  PER rate observed in this study was 32.9%, notwith-
standing the postoperative therapy used. Earlier studies
showed PER rates over 90% in 1 year.5 Currently, these val-
ues  remain high, but with greater variations in referral centers
(48–93%).5 In a retrospective study, De Cruz et al. observed PER
in  37.1% of 70 patients who underwent colonoscopy within 1
year after surgery,12 a ﬁgure similar to the number found in
this  series. Standardization in the prevention of postopera-
tive  recurrence therapy, as well as the use of biological agents,
may  have contributed to the reduction of PER in more  recent
publications.
Only  nine patients did not undergo postoperative ileo-
colonoscopy in this study, demonstrating a better attention in
j coloproctol (rio j). 2 0 1 4
Table 5 – Univariate analysis among factors related to
surgical  procedures per se and study groups regarding
the  presence of PER.
Variable w/o PER (n = 57) With PER (n = 28) P value
Isolated intestinal
resection
50  (87.7) 23 (82.1) 0.519
Type of operation 1.000
Open 49 (85.9) 25 (89.2)
Laparoscopic 8 (14.0) 3 (10.7)
Anastomosis 1.000
stapled 43 (75.4) 22 (78.5)
hand-sewn 14 (24.5) 6 (21.4)
Anastomosis type 0.274
side-to-side 42 (73.6) 24 (85.7)
end-to-end 15 (26.3) 4 (14.2)
Early complications 13  (22.8) 8 (28.5) 0.599
Abdominal sepsis 5 (8.7) 4 (14.2) 0.469
t
s
w
s
s
t
a
s
v
s
a
r
o
i
r
t
n
w
C
i
r
i
h
c
o
s
P
g
s
o
t
s
e
i
c
sAnastomotic
dehiscence
4 (7.0) 3 (10.7) 0.679
he follow-up of patients after surgical resection. However, in
ome cases the endoscopic examination was  performed later,
hich  may  have inﬂuenced the ﬁnding of luminal lesions,
ince  the longer the waiting time, the greater the risk of endo-
copic  recurrence.2 The mean postoperative ileocolonoscopy
ime was  of 12.8 (3–120) months, and the Mann–Whitney test
dapted  an exclusion of the more  disparate ﬁndings of the
tudy,  limiting this bias.
Comparing observationally the groups with PER (n = 27)
ersus  without PER (n = 58), it was  noted that there was no
tatistical  difference in relation to gender and age of patients
t  surgery. Gender does not seem to be a risk factor for
ecurrence7,13; on the other hand, the age factor at the time
f  surgery presents conﬂicting data.2 Ryan et al.,14 in a Cal-
fornian database, described an increased risk of surgical
ecurrence in patients previously operated when with less
han  20 years old (RR = 1.98, 95% CI 1.6–2.4).
Despite  the shorter duration of CD in PER group, there was
o  statistical difference between groups; thus, this variable
as  not established as a risk factor in this observational study.
D  of shorter duration may  indicate a more  aggressive behav-
or,  with rapid progression to complications and consequent
eoperations. Some studies suggest that CD of short duration
s  associated with postoperative recurrence,15,16 while others
ave  failed to demonstrate such a relationship.8,17 This lack of
onsistency  between studies may  be linked to the deﬁnition
f  the term “short” duration, making it difﬁcult to compare
tudies.7
Despite the higher proportion of smokers in the group with
ER  (25%, n = 7), there was  no statistical difference between
roups. Although not associated with PER in this study,
moking is the only modiﬁable independent factor for post-
perative  recurrence described with consistent evidence in
he literature.2,6,10 Besides increasing the risk of clinical and
urgical  recurrence, cigarette smoking is responsible for the
18levation  of PER rates. According to Cottone et al. in a study
nvolving  182 patients, PER was  described in 70% of smokers,
ompared with 35% in nonsmokers. Thus, it is essential to stop
moking in patients with CD because, in addition to reducing;3 4(3):141–147  145
disease  activity, this may  also reduce the risk of endoscopic,
clinical and postoperative surgical recurrence.7
Another consistent factor associated with recurrence is the
presence  of previous bowel resection. In a study conducted
by  Ng et al.,19 symptomatic recurrence was more  frequent in
patients  with previous resection (p = 0.06). Other publications
also  describe this association, mostly with clinical and surgical
recurrence.20,21 In the present study, there was  no correla-
tion between the history of previous intestinal resection and
endoscopic  recurrence. Approximately 30% of patients in both
groups  had prior intestinal surgery. Although there is consis-
tent  data in the literature on high risk for clinical and surgical
recurrence, previous bowel resections were not considered a
risk factor for endoscopic recurrence, maybe due to the limited
number  of patients in this sample.
Regarding the Montreal classiﬁcation, none of the items
showed statistical difference with respect to PER. Neverthe-
less,  patients with PER presented mainly with penetrating
CD  (57.1%, n = 16), which is considered one of the factors
with  scientiﬁc evidence for postoperative recurrence of CD.
A  meta-analysis by Simillis et al.22 described the penetrat-
ing  phenotype of the disease as associated with clinical and
surgical  recurrence, although signiﬁcant heterogeneity was
observed  in the 13 studies included. Again, few studies address
this  behavior of CD as a risk factor for PER, there is no con-
sensus  in the literature, and in our study this variable lacks
statistical  signiﬁcance.
A  cohort study of 907 patients in Sweden found an associ-
ation  of postoperative recurrence with perianal CD (OR = 1.6,
P  = 0.003) in patients undergoing ileocolic resection.23 Yang
et  al.24 also demonstrated this association with clinical recur-
rence  (P = 0.007). However, other studies failed to demonstrate
this  relationship, being few the trials published with high
level  of evidence to support perianal CD as a risk factor for
recurrence.7,10 In our study, a relationship between perianal
CD  and PER also was  not identiﬁed.
Regarding the medications used before surgery, patients
on  immunosuppressive and biologic drugs had similar rates
of  PER. On the other hand, patients on corticosteroids had
higher  PER rates (21%) compared to those without PER (42.8%),
with  statistical signiﬁcance (P = 0.044). Although reported in
some  studies,1,25 the use of corticosteroids in the preopera-
tive period presents no scientiﬁc evidence as a risk factor for
recurrence,  which goes against the observational ﬁndings of
this  study. However, many  patients with surgical indication
are  steroid-dependents, despite the immunosuppressive and
biologic  therapy, assuming an aggressive behavior and possi-
bly  establishing a higher rate of recurrence. It is not known
exactly  whether this association is a coincidence (patients
with  a more  severe disease, who ﬁnd in corticosteroids a med-
ication  for stabilization of symptoms before their operations),
or  represent a pharmacological effect of this medication on
the  occurrence of higher rates of PER.
There was  no difference between the association of pro-
cedures  with ileocolic resection, as well as the presence of
residual  CD on the ﬁndings of this observational study. Few
patients  required procedures of stricturoplasty (n = 3) and
enterectomy (n = 2), which may  have hampered the analysis
of  this variable. In a systematic review by Yamamoto et al., 26
in 90% of the patients the postoperative recurrence occurred
j). 2 0
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in areas without stricturoplasty and only in 3% at the sites of
plastic  procedures.
Residual CD was  observed in a higher percentage (21.4%) in
the  group with PER compared to those patients without PER
(14%).  This ﬁnding is closely related to areas in which it was
decided  to perform the stricturoplasty. However, studies sug-
gest  that the recurrence rates are low after the permanence of
residual  CD in areas of plastic procedures.27,28 There is no evi-
dence  to support stricturoplasty and residual CD as risk factors
for  PER.
Regarding the surgical procedure per se, although the
laparoscopic procedures reduce the systemic inﬂammatory
response, there is no evidence to suggest a reduction in the risk
of  PER. Three retrospective studies29–31 and three randomized
clinical trials32–34 showed no difference in rates of early or late
recurrence between open and laparoscopic procedures. The
conﬁguration  and type of anastomosis have also been tested
as  a risk factor for PER. In a randomized clinical trial with
a  mean follow-up of 12 months, the rates of PER and clini-
cal  recurrence were similar between groups with side-to-side
and  end-to-end anastomoses.20 As observed in the current
scientiﬁc evidence, in the present study, the data related to
the  surgical technique used were not considered as risk fac-
tors,  considering that differences between groups regarding
PER  were  not identiﬁed.
The  presence of granulomas in the surgical specimens
occurred in approximately 40% in both groups, with no asso-
ciation  with PER. Data regarding the predictive value of
granulomas in the surgical specimens are conﬂicting.2,7,13 In a
prospective  20-year study, Cullen et al.35 found an association
between granulomas and increased clinical and surgical recur-
rence.  In a meta-analysis including 21 studies and a total of
2236  patients with CD, the number of recurrences and reoper-
ations  was  signiﬁcantly higher in patients with versus without
granulomas.36 However, other publications37,38 and more
recently a German study did not reveal this association.39
Krause et al. followed 173 patients operated for CD for
over  27 years.40 Extended resections with normal margins
(10  cm)  were  associated with lower rates of reoperation, com-
pared  with economic resections (31% vs. 83%). On the other
hand,  Fazio et al. found no difference in postoperative recur-
rence  in patients undergoing resection with limited (2 cm)  or
enlarged (12 cm)  macroscopic margins.27 The extent of CD
inﬂuences  the length of resection, but both have an indeﬁ-
nite  impact in the postoperative recurrence.7,10 Considering
the fact that extended surgical margins do not represent clear
beneﬁts  in preventing recurrence, an economic resection of
the  macroscopically affected segment may  be the best strategy
in  patients with CD, given the likely need for future reoper-
ations,  as well as the risk of short bowel syndrome.7 In our
study,  the mean length of the specimen was  slightly larger
in  the group without PER (36.8 cm vs. 31.4 cm), but with no
difference  between groups (P = 0.536).
It  is known that biological therapy currently presents good
results  in the prevention of postoperative recurrence and is
indicated  for patients classiﬁed as high risk for recurrence.10According to the literature, the postoperative use of anti-TNFs
was  not related to PER in the present study, and a lower
utilization rate was  observed in the group with PER (60.7%),
compared to the group without PER (68.4%), but with no 1 4;3  4(3):141–147
statistical difference between their use or the type of drug
(inﬂiximab or adalimumab).
This  study has clear limitations that must be taken into
account  in the data analysis. In some patients the colonoscopy
was  performed 12 months after ileocolic resection, a fact that
inﬂuences  the rate of PER, since the risk of postoperative
recurrence is directly proportional to the time of postopera-
tive  colonoscopy. In addition to the limitations inherent to a
retrospective study, data from different units can inﬂuence
the  results, especially because this is an observational study,
with  no use of a ﬁxed prospective protocol. Although the insti-
tutions  involved in this study are considered referral centers
in  IBD, there is some variability in relation to the medical
therapy and surgical technique used and in the interpretation
of  endoscopic ﬁndings between centers. On the other hand,
the  small number of patients analyzed in some variables and
the  absence of a multivariate analysis also contributed to the
adoption  of a cautious interpretation of the results obtained
in  this series.
In  summary, in this ﬁrst study on the subject on Brazilian
patients, PER was observed in 32.9% of the patients. Preopera-
tive  corticosteroid use was  the only variable that was related to
PER, establishing the use of these drugs as a possible risk fac-
tor  for the occurrence of endoscopic recurrence after ileocolic
resection.
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